Device Trial Radar · NCT06887387
Wearable Devices for Patient Monitoring in Long QT Syndrome
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Apr 1, 2025
Primary completion
Sep 4, 2027
Study completion Sep 4, 2027
Sponsor
- Lead sponsor
- Queen Mary University of LondonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 20, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main research question of this study is whether wearable devices have utility in monitoring patients with Long QT syndrome.
Conditions
- Long QT Syndrome
Interventions
Wearable deviceDevice
This is an observational study that does not impact routine clinical care for participants
Primary outcomes
What the sponsor says the trial is designed to measure.
- 1. Determine the accuracy of repeated QT interval measurements using Fitbit-derived ECGs in patients with Long QT syndrome compared with the current standard (12-lead ECG and ambulatory monitors)Time frame: From enrollment to 3 months
- 2. Establish intra-patient QT variability from weekly Fitbit-ECGs and frequency of measurements over 500ms.Time frame: From enrollment to 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Barts and London Hospital NHS Trust
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.